Latest Breaking News On - Tessa therapeutics recognized - Page 1 : comparemela.com

Tessa Therapeutics Recognized in “Most Promising Off-the-Shelf Therapies” Category at Asia-Pacific Cell & Gene Therapy Excellence Awards 2022 Tessa developing allogeneic “off-the-shelf” CD30-CAR EBVST cell therapy – TT11X – targeting relapsed or refractory CD30-positive lymphomas GlobeNewswire September 14, 2022 SINGAPORE, Sept. 14, 2022 (GLOBE NEWSWIRE) Tessa Therapeutics Ltd. (Tessa), a clinical-stage.

Malcolm brennerIvan horakDave schemeliaAllogeneic vstsWilsonw cheungTessa therapeutics ltdUs food drug administrationScientific coEuropean medicine agencyBaylor college of medicineTessa therapeutics recognizedPromising off the shelfAsia pacific cellGene therapy excellence awardsGene therapy world asiaScientific co founder